CN103550525B - Drug for treating pubertal dysfunctional uterine bleeding - Google Patents
Drug for treating pubertal dysfunctional uterine bleeding Download PDFInfo
- Publication number
- CN103550525B CN103550525B CN201310573977.8A CN201310573977A CN103550525B CN 103550525 B CN103550525 B CN 103550525B CN 201310573977 A CN201310573977 A CN 201310573977A CN 103550525 B CN103550525 B CN 103550525B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- drug
- uterine bleeding
- dysfunctional uterine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating pubertal dysfunctional uterine bleeding, which is prepared from the following materials according to weight ratio: Banbiansu, syzygium aromaticum, cirrhopetalum, viburnum propinquum hemsl, leafy parnassia, manchurian catalpa bark, ruiliancao, joint vetch, whitebackleaf mallotus root, pteris vittata, kalimeris integrifolia, morinda umbellate, pen shell ligament, actinodaphne cupularis gamble, pepper, Chuihuotong, gmelin sealavender herb, russula virescens, tripterospermum, tuberose, Chunbujian, Zhenzhufeng, volvaria volvacea and willowweed. The components of the drug for treating pubertal dysfunctional uterine bleeding are all natural materials, and therefore, the drug has preferable safety and exact curative effect and is suitable for large-scale promotion in clinic.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of pubertal dysfunctional uterine bleeding.
Background technology
Adolescent Dysfunctional is more common in the 1-2 after menarche, the category of Ren Duoshu motherland medical science metrorrhagia, and modern medicine is thought, the adolescence development of ovary is unsound, estrogen and progestogen secretion is inharmonious, is the major pathogenetic factor of primary disease, common with maincenter maturation defect.Pubertal dysfunctional uterine bleeding (abbreviation Adolescent Dysfunctional) is commonly encountered diseases, the frequently-occurring disease of maiden, and sickness rate accounts for 20% of anovulatory dysfunctional uterine hemorrhage case, can have a strong impact on its physical and mental health, even cause severe anemia, thus affect work and study.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of pubertal dysfunctional uterine bleeding.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of pubertal dysfunctional uterine bleeding, it is made up of the material of following weight proportioning: Herba Elsholtziae Ciliatae 8 parts, Flos Caryophylli 9 parts, Herba Cirrohopetali Andersonii 7 parts, Viburnum propinquum Hemsl. 8 parts, Herba Parnassiae foliosae 8 parts, Cortex catalpae bungei 5 parts, auspicious even grass 3 parts, Herba Aeschynonenes Indicae 5 parts, Folium Malloti Apeltae 3 parts, Polystichum deltodon (Bak.) Diels 2 parts, Kalimeris integrifolia 3 parts, Radix Morindae Umbellatae 2 parts, Pinnapectinata L. 2 parts, Radix Actinodaphnes Cupularis 5 parts, 7 parts, Pericarpium Zanthoxyli, Ramulus Et folium Spiraeae Acuminatae 5 parts, Herba Limonii Gmelinii 6 parts, Russula vivesscens (Schaeff.) Franch. 9 parts, Herba Tripterospermi 2 parts, night 2 parts, fragrant flower, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 5 parts, Radix Callicarpae Bodinieri 2 parts, Volvariella volvacea (Bull.Ex Franch.) Singer． 8 parts and LIUYECAI 3 parts.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
In order to understand the present invention better, with reference to " Chinese medicine voluminous dictionary " second edition, being described as follows of some crude drug used in the present invention:
Russula vivesscens (Schaeff.) Franch.
Russula vivesscens (Schaeff.) Franch. is the sporophore of Mycophyta door fungus Russula vivesscens (Schaeff.) Franch..
Section belongs to classification: Russulaceae
Latin plant animal mineral name: Russula Virescens (Schaeff.) Fr. [Agari-cusvirescens Schaeff.]
Volvariella volvacea (Bull.Ex Franch.) Singer．
[section belongs to classification] Guang Bing mushroom section
[Latin literary fame] Fructificatio Volvarellae Volaceae
Whole compositions of the medicament for the treatment of pubertal dysfunctional uterine bleeding of the present invention are all natural materials, and safety is better, and clear curative effect, is suitable for large-scale promotion clinically.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take Herba Elsholtziae Ciliatae 8 grams, Flos Caryophylli 9 grams, Herba Cirrohopetali Andersonii 7 grams, Viburnum propinquum Hemsl. 8 grams, Herba Parnassiae foliosae 8 grams, Cortex catalpae bungei 5 grams, auspicious connect grass 3 grams, Herba Aeschynonenes Indicae 5 grams, Folium Malloti Apeltae 3 grams, Polystichum deltodon (Bak.) Diels 2 grams, Kalimeris integrifolia 3 grams, Radix Morindae Umbellatae 2 grams, Pinnapectinata L. 2 grams, Radix Actinodaphnes Cupularis 5 grams, 7 grams, Pericarpium Zanthoxyli, Ramulus Et folium Spiraeae Acuminatae 5 grams, Herba Limonii Gmelinii 6 grams, Russula vivesscens (Schaeff.) Franch. 9 grams, Herba Tripterospermi 2 grams, night 2 grams, fragrant flower, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 5 grams, Radix Callicarpae Bodinieri 2 grams, Volvariella volvacea (Bull.Ex Franch.) Singer． 8 grams and LIUYECAI 3 grams, add 8000 milliliters, water, heat 5 hours at 90 DEG C in the flask that condensing tube is housed, filter, filtrate is decoction of the present invention.
Experimental example
Physical data
Case all from outpatient service or inpatient, the age 12-19 year, 14.5 years old mean age, all unmarried, morbidity be limited in year in menarche 1-2, be hemorrhage time medical, bleeding time the shortest 5d, the longest 70d, the shortest 16d of the course of disease, the longest 26 months.Choose patient 50 example, all cases all get rid of whole body through B ultrasonic, gynaecological examination and experimental check and interior external genitalia matter sexually transmitted disease (STD) becomes, and diagnosis is clear and definite.
Diagnostic criteria
With reference to " new Chinese medicine guideline of clinical investigations " and " Clinical Obstetrics and Gynecology " diagnostic criteria about anovulatory dysfunctional uterine hemorrhage, the age should between 11 years old to 19 years old.Tcm diagnosis standard be menstrual period no periodic can follow, through amount or sudden and violent lower as note, or persistent vaginal bloody discharge, or both alternately occur; Doctor trained in Western medicine clinical manifestation is the confusion of the menstrual cycle, and menstrual period are different in size, how much indefinite through measuring, and many persons such as water notes sample, hemorrhage in dripping shape on a small quantity, even puts drop-wise hemorrhage.
Therapeutic Method
The decoction of preparation in embodiment 1 is used to treat.Every day 1 time, oral 100 milliliters at every turn, treatment 2 months continuously.
Efficacy assessment standard
With reference to State Administration of Traditional Chinese Medicine " Chinese medical disease Standardization of diagnosis and curative effect ".Cure: recover normal through amount, menstrual period, cycle, after drug withdrawal, 2 menstrual cycle can be continued.Take a turn for the better: recover normal through amount, menstrual period, cycle, 2 menstrual cycle can not be continued after drug withdrawal, or reduce through amount, or menstrual period shorten.Do not heal: after treatment, unchanged through amount, menstrual period, cycle.
Result
Treatment treatment, finds that all patients recovers normal through amount, menstrual period, cycle, can continue 2 menstrual cycle, therefore all meet the efficacy assessment standard of healing after drug withdrawal.
Untoward reaction and toxic and side effects monitoring
By detect patient blood pressure, pulse, whether there is Nausea and vomiting, dizzy clinical symptoms judges untoward reaction.Setting human normal systolic pressure is between 90-140mmHg, diastolic pressure is between 60-90mmHg, human normal pulse is 60-100 beat/min, blood pressure, the pulse of patient is measured at treatments period, find that the blood pressure and pulse recorded is all within normal range, the phenomenon not exceeding normal interval occurs, and does not occur Nausea and vomiting, dizzy clinical symptoms.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that this medicine does not have obvious toxic and side effects for human body.
Claims (1)
1. treat the medicament of pubertal dysfunctional uterine bleeding for one kind, it is characterized in that, it is made up of the material of following weight proportioning: Herba Elsholtziae Ciliatae 8 parts, Flos Caryophylli 9 parts, Herba Cirrohopetali Andersonii 7 parts, Viburnum propinquum Hemsl. 8 parts, Herba Parnassiae foliosae 8 parts, Cortex catalpae bungei 5 parts, auspicious connect grass 3 parts, Herba Aeschynonenes Indicae 5 parts, Folium Malloti Apeltae 3 parts, Polystichum deltodon (Bak.) Diels 2 parts, Kalimeris integrifolia 3 parts, Radix Morindae Umbellatae 2 parts, Pinnapectinata L. 2 parts, Radix Actinodaphnes Cupularis 5 parts, 7 parts, Pericarpium Zanthoxyli, Ramulus Et folium Spiraeae Acuminatae 5 parts, Herba Limonii Gmelinii 6 parts, Russula vivesscens (Schaeff.) Franch. 9 parts, Herba Tripterospermi 2 parts, night 2 parts, fragrant flower, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 5 parts, Radix Callicarpae Bodinieri 2 parts, Volvariella volvacea (Bull.Ex Franch.) Singer． 8 parts and LIUYECAI 3 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310573977.8A CN103550525B (en) | 2013-11-15 | 2013-11-15 | Drug for treating pubertal dysfunctional uterine bleeding |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310573977.8A CN103550525B (en) | 2013-11-15 | 2013-11-15 | Drug for treating pubertal dysfunctional uterine bleeding |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103550525A CN103550525A (en) | 2014-02-05 |
| CN103550525B true CN103550525B (en) | 2015-04-15 |
Family
ID=50004997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310573977.8A Expired - Fee Related CN103550525B (en) | 2013-11-15 | 2013-11-15 | Drug for treating pubertal dysfunctional uterine bleeding |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103550525B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189278B (en) * | 2014-08-27 | 2015-04-08 | 徐静 | Traditional Chinese medicine preparation for treating menstrual disorder and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091308A (en) * | 2011-01-19 | 2011-06-15 | 韩文正 | Medicament for treating dysfunctional uterine bleeding |
-
2013
- 2013-11-15 CN CN201310573977.8A patent/CN103550525B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091308A (en) * | 2011-01-19 | 2011-06-15 | 韩文正 | Medicament for treating dysfunctional uterine bleeding |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103550525A (en) | 2014-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101584797B (en) | Application of traditional Chinese medicine composition in preparing medicament for treating climacteric syndrome | |
| CN101700330B (en) | Traditional Chinese medicinal capsules for treating schizophrenia | |
| CN101584796B (en) | Application of traditional Chinese medicine composition in preparing medicament for treating melancholia | |
| CN102078565B (en) | Traditional Chinese medicine prescription for treating ectopic pregnancy | |
| CN103550525B (en) | Drug for treating pubertal dysfunctional uterine bleeding | |
| CN105287812A (en) | Medicine composition for treating irritable bowel syndromes and application of medicine composition | |
| CN101607031B (en) | Medicated wine for curing and preventing diabetes mellitus, preparation method and application method thereof | |
| CN103585573B (en) | Oral medicine for treating hysteromyoma | |
| CN100353964C (en) | Medicine for treating gynecopathy inflammation and its preparation method | |
| CN103550477B (en) | Medicament for treating herpes zoster | |
| CN104013704B (en) | Pharmaceutical composition for treating chronic pelvic inflammatory disease and preparation method of composition | |
| CN103301368B (en) | Medicament for treating hyperactivity | |
| CN1891255B (en) | Blood total flavone extract, and its preparing method and use | |
| CN104173513B (en) | A kind of Chinese medicine or health product being used for the treatment of puerperal constipation | |
| CN102058668A (en) | Traditional Chinese medicinal preparation for treating primary thrombocytopenia | |
| CN104474513A (en) | Medicine for treating endometriosis | |
| KR20170136213A (en) | Chinese medicine composition | |
| CN104491594A (en) | Pharmaceutical composition for treating premature ovarian failure | |
| CN102552808B (en) | Medicament for treating vaginal bleeding after abortion | |
| CN104587019A (en) | Medicine composition for treating climacteric functional uterine bleeding | |
| CN103550600B (en) | Drug for treating dysfunctional uterine bleeding | |
| CN105106657B (en) | A kind of medicament for drug induced abortion | |
| CN104306708A (en) | Medicine for treating spleen deficiency type menstrual period irregularity and application thereof | |
| CN103550483B (en) | A kind of preparation method for the treatment of the medicament of type 2 diabetes mellitus | |
| CN103877475B (en) | Oral pharmaceutical preparation for treating mania |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150415 Termination date: 20151115 |
|
| EXPY | Termination of patent right or utility model |